APOE and coronary artery disorder: Lower cognitive decline was also demonstrated in statin users with a history of coronary heart disease (CHD) compared with nonusers (9), and statins may be more effective in apolipoprotein e ε4 allele (APOE4) carriers, as this is the major genetic risk factor for AD and is associated with higher cholesterol concentration (11).